HSPA5 and cancer: Site-specific deletion of GRP78 in the prostate epithelium suppresses prostate tumorigenesis [45], and knockdown of GRP78 sensitizes various cancer cells to chemotoxic, anti-hormonal, DNA damaging, and anti-angiogenesis agents [46].